| | |
Diagnostic Substances News
|
| | View:
Latest News | Top Stories | | | 1.
|
Biomoda Honors Veterans with Pledge to Lower Rate of Lung Cancer
-
Business Wire
-
2 hours, 8 minutes ago
ALBUQUERQUE, N.M.----Biomoda, Inc. President John Cousins called upon governors in all 50 states to proclaim November “Lung Cancer Awareness Month” on behalf of veterans and their families and pledged to continue the company’s focus on veterans in the research, development and commercialization of diagnostic technology for detection of early-stage lung cancer.
| | | 2.
|
BrainStorm Stem Cell Therapy Treatment Shown To Be More Effective Than Other Current Potential Stem Cell Treatments
-
Business Wire
-
Mon 6:53 am ET
NEW YORK & PETACH TIKVAH, Israel----BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company’s therapeutic approach for treating neurodegenerative diseases was shown to be superior to other current potential stem cell treatments.
| | | 3.
|
Myriad Misses by a Penny
-
Zacks.com
-
Fri Nov 6
Myriad's first-quarter earnings of 31 cents per share was a penny behind the Zacks Consensus Estimate.
| | | 4.
|
Immunomedics Announces First Quarter Fiscal 2010 Results and Clinical Program Developments
-
GlobeNewswire
-
Fri Nov 6
MORRIS PLAINS, N.J. -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported financial results for the first quarter ended September 30, 2009.
| | | 5.
|
Celldex Therapeutics to Present at Merriman Curhan Ford's Investor Summit 2009
-
Business Wire
-
Thu Nov 5
NEEDHAM, Mass.----Celldex Therapeutics, Inc. today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at Merriman Curhan Ford’s 6th Annual Investor Summit at the Sofitel Hotel, New York City on Tuesday, November 10, 2009 at 2:40 pm, EST.
| | | 6.
|
Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent
-
Business Wire
-
Thu Nov 5
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office has issued U.S.
| | | 7.
|
Myriad Genetics to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
-
GlobeNewswire
-
Wed Nov 4
SALT LAKE CITY -- Myriad Genetics, Inc. announced today that Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., is scheduled to present an overview of the Company at the Lazard Capital Markets Sixth Annual Healthcare Conference, at 9:30 a.m.
| | | 8.
|
Myriad Genetics 1Q profit doubles on test sales
-
AP
-
Wed Nov 4
Molecular diagnostics company Myriad Genetics Inc. said its fiscal first-quarter profit doubled on higher revenue from cancer tests.
| | | 9.
|
AMAG 3Q loss narrows slightly on anemia drug sales
-
AP
-
Thu Oct 29
Biotechnology company AMAG Pharmaceuticals Inc. said Thursday that its third-quarter loss narrowed on higher sales of the anemia drug Feraheme.
| | | 10.
|
Akorn, Inc. Announces Third Quarter 2009 Earnings Release and Conference Call Information
-
PR Newswire
-
Mon Oct 26
Akorn, Inc. will release third quarter 2009 earnings Tuesday, November 10, before the market opens.
| |
| |
|
